Position
Chief Financial Officer
Company
Surrozen
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Surrozen, Inc has appointed Andrew P Maleki as the Chief Financial Officer, effective November 6, 2025. He was granted inducement stock option awards covering 50,000 shares of common stock to facilitate his acceptance of the role.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Ladder Bio Inc. Appoints Eric Heil as Chief Executive Officer (November 12, 2025)
- Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer (November 13, 2025)
- RION Vet Appoints Mark Herthel as Chief Executive Officer (November 11, 2025)
- Prokarium Appoints Ibs Mahmood as Chief Executive Officer (November 11, 2025)
- Celldex Therapeutics Appoints Teri Lawver as Chief Commercial Officer (November 11, 2025)
- Cytokinetics Appoints Jeffrey J. Hessekiel as Executive Vice President, Chief Legal and Administrative Officer (November 14, 2025)
Who to call at Surrozen, and when
A new leader at Surrozen brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Surrozen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Surrozen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Surrozen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Surrozen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Surrozen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.